Clinical trial of nimodipine for single attacks of classic migraine.
Jensen K, Tfelt-Hansen P, Lauritzen M, +1 more·Cephalalgia : an international journal of headache
In a randomized, double-blind cross-over study, 43 patients with classic migraine received 40 mg Nimodipine and placebo as sublingual capsules. There was no significant effect on patients' preference, development of headache, need for escape medicine, duration of headache, severity of headache or headache index. Consid…